DataMeds AI MEDS Growth Metrics (2024-2026)

NASDAQ MEDS
$2.06 -0.13 (-5.94%)
At close: Oct 27, 2026 · 4:00 PM EDT
Reported Financials

DataMeds AI Quarterly Growth Metrics

Periods 9 quarters
Latest Jun 2026

DataMeds AI growth metrics data for the quarter ended Jun 2026. These growth metrics cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Total Debt (QoQ) 11,882.90%101.22%-3.45%23.84%-18.53%18.24%-30.84%
Total Debt Growth (1y) 3,323.69%28,729.09%96.01%15.18%-17.50%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -96.63%2,649.78%-98.62%281.72%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) -95.11%
Revenue (QoQ) 12,638.81%118.73%-12.47%-28.28%-61.33%-44.55%-6.65%
Revenue Growth (1y) 17,391.84%-46.90%-86.54%-85.64%
Return on Sales [ROS] (QoQ)ROS (QoQ) 0.13M56.00-0.03M0.02M-0.10M-0.05M0.11M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 0.12M-0.10M-0.15M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ) -0.06M-0.10M-0.03M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M0.00M-0.04M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M-0.01M-0.01M-948.00
Return on Assets [ROA] Growth (1y)ROA Growth (1y) -0.02M
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) -10.25%-11.40%-12.87%-14.70%-12.15%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -40.91%-42.16%
Operating Margin (QoQ) 0.13M56.00-0.03M0.02M-0.10M-0.05M0.11M
Operating Margin Growth (1y) 0.12M-0.10M-0.15M-0.01M
Operating Income (QoQ)Op. Inc (QoQ) -618.39%-204.50%-114.78%-736.51%82.45%-473.57%19.64%76.27%
Operating Income Growth (1y)Op. Inc Growth (1y) -39,201.40%-859.90%-1,708.11%-576.50%80.81%
Net Margin (QoQ) 0.13M-200.00-0.03M0.02M-0.11M-0.05M0.12M
Net Margin Growth (1y) 0.12M-0.11M-0.16M-0.02M
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -590.94%-225.08%-132.01%-648.68%79.43%-414.33%18.84%72.20%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -38,916.03%-1,061.79%-1,738.12%-543.00%76.13%
Net Income (QoQ) -590.94%-225.08%-132.01%-648.68%79.43%-414.33%18.84%72.20%
Net Income Growth (1y) -38,916.03%-1,061.79%-1,738.12%-543.00%76.13%
Net Cash Flow (QoQ)NCF (QoQ) -171.45%448.99%-67.61%532.79%-240.88%281.66%-209.91%100.22%
Net Cash Flow Growth (1y)NCF Growth (1y) 411.01%-907.61%424.49%-1,879.89%-99.38%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -1,742.90%97.10%57.11%-426.74%83.78%-376.48%-30.79%89.97%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) -20.58%98.94%-74.57%-432.40%89.87%
Income After Tax (QoQ) -590.94%-225.08%-132.01%-648.68%79.43%-414.33%18.84%72.20%
Income After Tax Growth (1y) -38,916.03%-1,061.79%-1,738.12%-543.00%76.13%
Gross Profit (QoQ) 20,086.35%139.56%-44.53%-26.98%-54.32%-3,500.61%102.17%
Gross Profit Growth (1y) 19,492.33%-55.68%-729.13%-75.42%
Gross Margin (QoQ) 0.00M87.00-369.0012.00118.00-0.05M0.05M
Gross Margin Growth (1y) 0.00M-152.00-0.05M454.00
Free Cash Flow (QoQ)FCF (QoQ) 956.30%214.46%-352.87%48.64%-54.29%45.39%-454.31%45.77%
Free Cash Flow Growth (1y)FCF Growth (1y) -4,413.63%-730.08%-209.42%-139.85%-153.30%
FCF Margin (QoQ) -0.07M0.00M874.000.00M0.00M-0.03M0.02M
FCF Margin Growth (1y) -0.08M-0.01M-0.04M-0.02M
EPS (Diluted) (QoQ) -573.21%-208.25%-137.67%-581.41%82.71%-327.14%14.96%81.14%
EPS (Diluted) Growth (1y) -33,507.56%-763.25%-1,096.19%-328.01%88.15%
EPS (Basic) (QoQ) -573.21%-208.25%-137.67%-581.41%82.71%-327.14%14.96%81.14%
EPS (Basic) Growth (1y) -33,507.56%-763.25%-1,096.19%-328.01%88.15%
EBT (QoQ) -590.94%-225.08%-132.01%-648.68%79.43%-414.33%18.84%72.20%
EBT Margin (QoQ) 0.13M-200.00-0.03M0.02M-0.11M-0.05M0.12M
EBT Margin Growth (1y) 0.12M-0.11M-0.16M-0.02M
EBT Growth (1y) -38,916.03%-1,061.79%-1,738.12%-543.00%76.13%
EBIT (QoQ) -618.39%-204.50%-114.78%-736.51%82.45%-473.57%19.64%76.27%
EBIT Margin (QoQ) 0.13M56.00-0.03M0.02M-0.10M-0.05M0.11M
EBIT Margin Growth (1y) 0.12M-0.10M-0.15M-0.01M
EBIT Growth (1y) -39,201.40%-859.90%-1,708.11%-576.50%80.81%
EBITDA Margin (QoQ) 0.13M-224.00-0.03M0.02M-0.09M-0.05M0.12M
EBITDA Margin Growth (1y) 0.12M-0.10M-0.15M0.00M
Cash from Operations (QoQ)Cash from Ops. (QoQ) 956.30%214.46%-352.87%48.64%-54.29%45.39%-454.31%45.77%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -4,413.63%-730.08%-209.42%-139.85%-153.30%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) 354.02%-134.03%51.70%-67.58%-15.51%19.69%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) 30.02%-131.82%24.91%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) 144.72%-83.31%906.96%-98.99%21.51%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 75,291.20%-95.86%-97.94%
Assets (QoQ) 1.27%-6.61%-2.67%-42.29%-1.09%
Assets Growth (1y) 16,844.08%-46.87%-48.11%

DataMeds AI Growth Metrics API

Pull DataMeds AI's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MEDS&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY